Primary Site >> Pancreatic Cancer

Gene >> IRS1

Journal: Int J Oncol. 1996 Sep;9(3):487-92.
Title: Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1.
Author: Bergmann, U|Funatomi, H|Kornmann, M|Ishiwata, T|Beger, H|Korc, M
PMID: 21541539
Journal: Biochem Biophys Res Commun. 1996 Mar 27;220(3):886-90.
Title: Increased expression of insulin receptor substrate-1 in human pancreatic cancer.
Author: Bergmann, U|Funatomi, H|Kornmann, M|Beger, H G|Korc, M
PMID: 8607861
Journal: Br J Cancer. 2005 Mar 14;92(5):921-8.
Title: Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions.
Author: Prokopchuk, O|Liu, Y|Henne-Bruns, D|Kornmann, M
PMID: 15714203
Journal: Cancer Res. 2005 Oct 15;65(20):9164-8.
Title: Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells.
Author: Asano, Takayuki|Yao, Yixin|Shin, Sonyo|McCubrey, James|Abbruzzese, James L|Reddy, Shrikanth A G
PMID: 16230374
Journal: Cancer Res. 2007 Sep 15;67(18):8856-64.
Title: RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205.
Author: Li, Jonathan Chi-Hang|Li, Ronghao
PMID: 17875727
Journal: Eur J Cancer. 2008 Jul;44(11):1577-86.
Title: Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis.
Author: Moser, Christian|Schachtschneider, Philipp|Lang, Sven A|Gaumann, Andreas|Mori, Akira|Zimmermann, Johann|Schlitt, Hans J|Geissler, Edward K|Stoeltzing, Oliver
PMID: 18445520
Journal: Cancer Res. 2009 Feb 15;69(4):1350-7.
Title: Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta.
Author: Kwon, Junhye|Stephan, Susann|Mukhopadhyay, Ananya|Muders, Michael H|Dutta, Shamit K|Lau, Julie S|Mukhopadhyay, Debabrata
PMID: 19190347
Journal: Front Biosci (Landmark Ed). 2009 Jan 1;14:2170-80.
Title: 2-Methoxyestradiol mediated signaling network in pancreatic cancer.
Author: Basu, Aruna|Haldar, Subrata
PMID: 19273191
Journal: Mol Cancer Res. 2010 Aug;8(8):1152-63.
Title: Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein.
Author: Sugita, Hiroki|Kaneki, Masao|Furuhashi, Satoshi|Hirota, Masahiko|Takamori, Hiroshi|Baba, Hideo
PMID: 20663861
Journal: Gastroenterology. 2010 Aug;139(2):464-73, 473.e1-3.
Title: Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.
Author: Dong, Xiaoqun|Javle, Milind|Hess, Kenneth R|Shroff, Rachna|Abbruzzese, James L|Li, Donghui
PMID: 20416304
Journal: Cancer Epidemiol. 2012 Apr;36(2):206-11.
Title: Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer.
Author: Dong, Xiaoqun|Li, Yanan|Tang, Hongwei|Chang, Ping|Hess, Kenneth R|Abbruzzese, James L|Li, Donghui
PMID: 21852217
Journal: Clin Cancer Res. 2012 May 15;18(10):2838-49.
Title: Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Author: Speisky, Daniela|Duces, Aurelie|Bieche, Ivan|Rebours, Vinciane|Hammel, Pascal|Sauvanet, Alain|Richard, Stephane|Bedossa, Pierre|Vidaud, Michel|Murat, Arnaud|Niccoli, Patricia|Scoazec, Jean-Yves|Ruszniewski, Philippe|Couvelard, Anne
PMID: 22461457
Journal: BMC Cancer. 2013 May 10;13:235.
Title: Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.
Author: Karnevi, Emelie|Said, Katarzyna|Andersson, Roland|Rosendahl, Ann H
PMID: 23663483
Journal: J Biol Chem. 2014 Aug 1;289(31):21694-705.
Title: The prolyl peptidases PRCP/PREP regulate IRS-1 stability critical for rapamycin-induced feedback activation of PI3K and AKT.
Author: Duan, Lei|Ying, Guoguang|Danzer, Brian|Perez, Ricardo E|Shariat-Madar, Zia|Levenson, Victor V|Maki, Carl G
PMID: 24936056
Journal: PLoS One. 2015 Jan 21;10(1):e0116869.
Title: A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas.
Author: Permuth-Wey, Jennifer|Chen, Y Ann|Fisher, Kate|McCarthy, Susan|Qu, Xiaotao|Lloyd, Mark C|Kasprzak, Agnieszka|Fournier, Michelle|Williams, Vonetta L|Ghia, Kavita M|Yoder, Sean J|Hall, Laura|Georgeades, Christina|Olaoye, Funmilayo|Husain, Kazim|Springett, G
PMID: 25607660
Journal: BMC Cancer. 2015 Apr 4;15:223.
Title: Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors.
Author: Urtasun, Nerea|Vidal-Pla, Anna|Perez-Torras, Sandra|Mazo, Adela
PMID: 25886138
Journal: Genome Med. 2016 May 3;8(1):38.
Title: Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
Author: Rajamani, Deepa|Bhasin, Manoj K
PMID: 27137215
Journal: Cell Prolif. 2017 Dec;50(6).
Title: Long non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1.
Author: Wang, Gang|Pan, Jingen|Zhang, Lu|Wei, Yajun|Wang, Cheng
PMID: 28940804